Literature DB >> 33430906

Microarray expression profile of mRNAs and long noncoding RNAs and the potential role of PFK-1 in infantile hemangioma.

Kaiying Yang1, Xuepeng Zhang2, Linwen Chen3, Siyuan Chen4, Yi Ji5.   

Abstract

BACKGROUND: Infantile hemangioma (IH) is the most common benign tumor in children. Long noncoding RNAs (lncRNAs) play a critical role in tumorigenesis. However, the expression levels and biological functions of lncRNAs in IH have not been well-studied. This study aimed to analyze the expression profile of lncRNAs and mRNAs in proliferating and involuting IHs.
METHODS: The expression profiles of lncRNAs and mRNAs in proliferating and involuting IHs were identified by microarray analysis. Subsequently, detailed bioinformatics analyses were performed. Finally, quantitative real-time polymerase chain reaction (qRT-PCR) and immunohistochemistry (IHC) analyses were conducted to validate the microarray results.
RESULTS: In total, 146 differentially expressed (DE) lncRNAs and 374 DE mRNAs were identified. The DE mRNAs were enriched mostly in angiogenesis-related biological processes (BPs) and pathways by bioinformatics analysis. In addition, metabolism-related BPs (e.g., "glycogen biosynthetic process" and "metabolic process") and pathways (e.g., "oxidative phosphorylation") were identified. A lncRNA-mRNA co-expression network was constructed from 42 DE lncRNAs and 217 DE mRNAs. Twelve lncRNAs were predicted to have cis-regulated target genes. The microarray analysis results were validated by qRT-PCR using 5 randomly selected lncRNAs and 13 mRNAs. The IHC results revealed that both LOXL2 and FPK-1 exhibited higher protein expression levels in proliferating IH than in involuting IH. Moreover, inhibition of PFK-1 could suppress hemangioma-derived endothelial cell proliferation and migration, induce cell arrest, and reduce glucose uptake and lactate and ATP production.
CONCLUSIONS: The findings suggest that the identified DE lncRNAs and mRNAs may be associated with the pathogenesis of IH. The data presented herein can improve our understanding of IH development and provide direction for further studies investigating the mechanism underlying IH.

Entities:  

Keywords:  Bioinformatics analysis; Infantile hemangioma; Long noncoding RNA; Microarray; PFK-1; mRNA

Year:  2021        PMID: 33430906      PMCID: PMC7802351          DOI: 10.1186/s13008-020-00069-y

Source DB:  PubMed          Journal:  Cell Div        ISSN: 1747-1028            Impact factor:   5.130


  45 in total

1.  DAVID: Database for Annotation, Visualization, and Integrated Discovery.

Authors:  Glynn Dennis; Brad T Sherman; Douglas A Hosack; Jun Yang; Wei Gao; H Clifford Lane; Richard A Lempicki
Journal:  Genome Biol       Date:  2003-04-03       Impact factor: 13.583

2.  Role of PFKFB3-driven glycolysis in vessel sprouting.

Authors:  Katrien De Bock; Maria Georgiadou; Sandra Schoors; Anna Kuchnio; Brian W Wong; Anna Rita Cantelmo; Annelies Quaegebeur; Bart Ghesquière; Sandra Cauwenberghs; Guy Eelen; Li-Kun Phng; Inge Betz; Bieke Tembuyser; Katleen Brepoels; Jonathan Welti; Ilse Geudens; Inmaculada Segura; Bert Cruys; Franscesco Bifari; Ilaria Decimo; Raquel Blanco; Sabine Wyns; Jeroen Vangindertael; Susana Rocha; Russel T Collins; Sebastian Munck; Dirk Daelemans; Hiromi Imamura; Roland Devlieger; Mark Rider; Paul P Van Veldhoven; Frans Schuit; Ramon Bartrons; Johan Hofkens; Peter Fraisl; Sucheta Telang; Ralph J Deberardinis; Luc Schoonjans; Stefan Vinckier; Jason Chesney; Holger Gerhardt; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell       Date:  2013-08-01       Impact factor: 41.582

3.  LncRNA-MALAT1 promotes tumorogenesis of infantile hemangioma by competitively binding miR-424 to stimulate MEKK3/NF-κB pathway.

Authors:  Miao-Miao Li; Chang-Xian Dong; Bin Sun; Hong-Zhao Lei; Yan-Lin Wang; Yu-Bin Gong; Long-Long Sun; Zheng-Wei Sun
Journal:  Life Sci       Date:  2019-10-11       Impact factor: 5.037

4.  lncRNA MEG3 Suppresses the Tumorigenesis of Hemangioma by Sponging miR-494 and Regulating PTEN/ PI3K/AKT Pathway.

Authors:  Yuxin Dai; Yongkun Wan; Mingke Qiu; Shuqing Wang; Chang Pan; Yang Wang; Jingmin Ou
Journal:  Cell Physiol Biochem       Date:  2018-12-14

5.  Partial and transient reduction of glycolysis by PFKFB3 blockade reduces pathological angiogenesis.

Authors:  Sandra Schoors; Katrien De Bock; Anna Rita Cantelmo; Maria Georgiadou; Bart Ghesquière; Sandra Cauwenberghs; Anna Kuchnio; Brian W Wong; Annelies Quaegebeur; Jermaine Goveia; Francesco Bifari; Xingwu Wang; Raquel Blanco; Bieke Tembuyser; Ivo Cornelissen; Ann Bouché; Stefan Vinckier; Santiago Diaz-Moralli; Holger Gerhardt; Sucheta Telang; Marta Cascante; Jason Chesney; Mieke Dewerchin; Peter Carmeliet
Journal:  Cell Metab       Date:  2013-12-12       Impact factor: 27.287

6.  Effects of propranolol on the proliferation and apoptosis of hemangioma-derived endothelial cells.

Authors:  Yi Ji; Kai Li; Xianmin Xiao; Shan Zheng; Ting Xu; Siyuan Chen
Journal:  J Pediatr Surg       Date:  2012-12       Impact factor: 2.545

Review 7.  Long non-coding RNAs: new players in cell differentiation and development.

Authors:  Alessandro Fatica; Irene Bozzoni
Journal:  Nat Rev Genet       Date:  2013-12-03       Impact factor: 53.242

8.  Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis.

Authors:  Jong-Ho Lee; Rui Liu; Jing Li; Chuanbao Zhang; Yugang Wang; Qingsong Cai; Xu Qian; Yan Xia; Yanhua Zheng; Yuji Piao; Qianming Chen; John F de Groot; Tao Jiang; Zhimin Lu
Journal:  Nat Commun       Date:  2017-10-16       Impact factor: 14.919

9.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets.

Authors:  Yingyao Zhou; Bin Zhou; Lars Pache; Max Chang; Alireza Hadj Khodabakhshi; Olga Tanaseichuk; Christopher Benner; Sumit K Chanda
Journal:  Nat Commun       Date:  2019-04-03       Impact factor: 14.919

View more
  1 in total

Review 1.  Infantile hepatic hemangiomas: looking backwards and forwards.

Authors:  Xue Gong; Yanan Li; Kaiying Yang; Siyuan Chen; Yi Ji
Journal:  Precis Clin Med       Date:  2022-02-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.